Introduction Cerebrovascular complications rate in patients treated with extracorporeal
membrane oxygenation (ECMO) is about 7%. Ischemic stroke may be caused by solid or …

Background Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been
increasingly used over the last decade in patients with refractory cardiogenic shock. ECMO …

Objectives: To describe donors after brain death with ongoing extracorporeal membrane
oxygenation and to analyze the outcome of organs transplanted from these donors. Design …

Objectives: To investigate the presence of cognitive dysfunction and brain lesions in long-
term survivors after treatment with extracorporeal membrane oxygenation for severe …

BACKGROUND Venovenous extracorporeal membrane oxygenation (VV ECMO) can
support trauma patients with severe respiratory failure. Use in traumatic brain injury (TBI) …

Introduction Critically ill patients requiring extracorporeal membrane oxygenation (ECMO)
are at increased risk for developing nosocomial infections owing to their underlying disease …

Although the fast-growing metagenomic next-generation sequencing (mNGS) has been
used in diagnosing infectious diseases, low detection rate of mNGS in detecting pathogens …

Purpose Cardiogenic shock due to post-resuscitation myocardial dysfunction is a major
cause of mortality among patients hospitalized after cardiac arrest (CA). Veno-arterial …

The use of extracorporeal membrane oxygenation (ECMO) for acute cardiac and/or
respiratory failure has grown exponentially in the past several decades. Systemic …

Lung transplant is increasingly used as a treatment option for end-stage lung disease. The
demand for lung transplantation is increasing, but the number of donor lungs is limited …